Skip to main content
CTOS 2023 Main banner
Final Program


Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Session 13: Retroperitoneal and Abdominal Sarcomas

Saturday, November 4, 2023
2:00 PM – 3:00 PM  

    Chair(s)

  • Rebecca Gladdy, MD, PhD (she/her/hers)

    Surgical Oncologist Clinician-Scientist Associate Professor of Surgery
    Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON
    Toronto, Ontario, Canada

    • Moderator(s)

  • Aimee Crago, MD, PhD, FACS (she/her/hers)

    Associate Attending Surgeon
    Memorial Sloan Kettering Cancer Center
    New York, New York, United States

  • PR

    Paul Ridgway, n/a

    Consultant Surgeon
    Tallaght University Hospital
    Dublin, Dublin, Ireland

Presentations:

  • 2:00 PM – 3:00 PM  
    A NOVEL SURGICAL COMPLEXITY SCORE TO PREDICT POSTOPERATIVE MORBIDITY FOR PRIMARY RETROPERITONEAL SARCOMA: THE FIRST TARPSWG STUDY FROM THE PROSPECTIVE RESAR REPOSITORY

    Author: Mark Fairweather, MD – Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston

    Co-Author: Jolissaint S. Joshua, MD, MSc – Department of Surgery, Memorial Sloan Kettering, Cancer Center

    Co-Author: Marco Fiore, MD, FEBS, FACS – Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Dirk Strauss, MD – Royal Marsden NHS Foundation Trust

    Co-Author: Sylvie Bonvalot, MD, PhD – Institut Curie

    Co-Author: Samuel Ford, MD, PhD – Department of Surgery, University Hospitals Birmingham

    Co-Author: Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute/ Antoni van Leeuwenhoek

    Co-Author: Carol Swallow, MD, PhD – Mount Sinai Hospital, Toronto, ON, Canada

    Co-Author: Piotr Rutkowski, MD, PhD – Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Department of Soft Tissue/Bone Sarcoma and Melanoma

    Co-Author: David E Gyorki, MD (he/him/his) – Peter MacCallum Cancer Centre

    Co-Author: Migalie Fau, MD – Department of Surgery, Institut Bergonie

    Co-Author: John Mullinax, MD – Moffitt Cancer Center

    Co-Author: Markus Albertsmeier, MD – Department of General, Visceral and Transplantation Surgery, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Germany

    Co-Author: Carolyn Nessim, MD (she/her/hers) – Department of Surgery, University of Ottawa

    Co-Author: Vittorio Lorenzo Quagliuolo, MD – IRCCS Humanitas Research Hospital

    Co-Author: Valerie P. Grignol, MD – The James Cancer Hospital / The Ohio State University

    Co-Author: Kenneth Cardona, MD – Department of Surgery, Winship Cancer Institute, Emory University

    Co-Author: José Antonio Gonzalez, MD, PhD – Department of Surgery, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

    Co-Author: Elisabetta Pennacchioli, MD – Division of Melanoma, Sarcoma, and Rare Tumor Surgery, European Institute of Oncology

    Co-Author: Marko Novak, MD – Department of Surgery, Institute of Oncology Ljubljana

    Co-Author: Marco Rastrelli, MD – Department of Surgery, Veneto Institute of Oncology IOV-IRCCS

    Co-Author: Sergio Valeri, MD – Sarcoma Surgery, Fondazione Policlinico Universitario Campus Bio-Medico

    Co-Author: Michelle Wilkinson, MD PhD – Sarcoma Unit, Department of Surgery, Royal Marsden Hospital, Royal Marsden NHS Foundation Trust

    Co-Author: Dimitri Tzanis, MD, PhD (he/him/his) – Institut Curie

    Co-Author: Yvonne Schrage, MD, PhD – Netherlands Cancer Institute/ Antoni van Leeuwenhoek

    Co-Author: Rebecca Gladdy, MD, PhD (she/her/hers) – Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON

    Co-Author: Jacek Skoczylas, MD – Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology

    Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his) – Brigham and Women’s Hospital/Harvard Medical School

  • 2:00 PM – 3:00 PM  
    IMPACT OF CENTER VOLUME ON INDIVIDUAL PROGNOSTICATION OF PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA: UPDATE OF SARCULATOR NOMOGRAMS

    Author: Dario Callegaro, MD – Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Francesco Barretta, PhD – Fondazione IRCCS IStituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his) – Brigham and Women’s Hospital/Harvard Medical School

    Co-Author: Wendy Johnston, PhD (she/her/hers) – Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada

    Co-Author: Dirk Strauss, MD – Royal Marsden NHS Foundation Trust

    Co-Author: Charles Honorè, MD, PhD – Institut Gustave Roussy, Villejuif, France

    Co-Author: Sylvie Bonvalot, MD, PhD – Institut Curie

    Co-Author: Mark Fairweather, MD – Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston

    Co-Author: Piotr L. Rutkowski, MD, PhD – Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw Poland

    Co-Author: Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute/ Antoni van Leeuwenhoek

    Co-Author: Rebecca Gladdy, MD, PhD (she/her/hers) – Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON

    Co-Author: Fabio Tirotta, MD – Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust

    Co-Author: Dimitri Tzanis, MD, PhD (he/him/his) – Institut Curie

    Co-Author: Jacek Skoczylas, MD – Maria Sklodowska-Curie National Research Institute of Oncology

    Co-Author: Rick Haas, MD, PhD (he/him/his) – The Netherlands Cancer Institute

    Co-Author: Rosalba Miceli, MD, PhD (she/her/hers) – Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Carol Swallow, MD, PhD – Mount Sinai Hospital, Toronto, ON, Canada

    Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • 2:00 PM – 3:00 PM  
    THE PET-RPS STUDY: A PROSPECTIVE EVALUATION OF PET-MR IN PREDICTING RESPONSE TO PREOPERATIVE CHEMOTHERAPY FOR PRIMARY RETROPERITONEAL SARCOMA (RPS)

    Author: Deanna Ng, MD, PhD – University of Toronto

    Co-Author: Wendy Johnston, PhD (she/her/hers) – Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada

    Co-Author: Albiruni Ryan Abdul Razak, MB BCh, BM BCh – Princess Margaret Cancer Center

    Co-Author: Rebecca Gladdy, MD, PhD (she/her/hers) – Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON

    Co-Author: Abha Gupta, MD MSc – Princess Margaret Cancer Center

    Co-Author: Patrick Veit-Haibach, MD – University Health Network

    Co-Author: Fahima Dossa, MD, PhD – Memorial Sloan Kettering Cancer Center

    Co-Author: Geoffrey Watson, MD – Mount Sinai Hospital / University of Toronto

    Co-Author: Savtaj Brar, M.Sc., MD (he/him/his) – Mount Sinai Hospital

    Co-Author: Ur Metser, MD – University of Toronto

    Co-Author: Carol Swallow, MD, PhD – Mount Sinai Hospital, Toronto, ON, Canada

  • 2:00 PM – 3:00 PM  
    HISTOLOGIC SUBVARIANTS OF RETROPERITONEAL WELL-DIFFERENTIATED LIPOSARCOMA SHOW EVIDENCE OF CLINICAL AND GENOMIC PROGRESSION TOWARD DEDIFFERENTIATED LIPOSARCOMA

    Author: George Z. Li, MD (he/him/his) – Memorial Sloan Kettering Cancer Center

    Co-Author: Evan Seffar, MS – Memorial Sloan Kettering Cancer Center

    Co-Author: Jay S. Lee, MD – Duke University

    Co-Author: Karissa Whiting, MS – Memorial Sloan Kettering Cancer Center

    Co-Author: Li-Xuan Qin, PhD (she/her/hers) – Memorial Sloan Kettering Cancer Center

    Co-Author: Edmund K. Bartlett, MD – Memorial Sloan Kettering Cancer Center

    Co-Author: Aimee M. Crago, MD, PhD, FACS (she/her/hers) – Memorial Sloan Kettering Cancer Center

    Co-Author: Murray F Brennan, MD – Memorial Sloan Kettering Cancer Center

    Co-Author: Meera Hameed, MD – Memorial Sloan Kettering Cancer Center

    Co-Author: Samuel Singer, MD, FACS – Memorial Sloan Kettering Cancer Center

  • 2:00 PM – 3:00 PM  
    EARLY SCREENING AND TIMELY INTERVENTION CAN IMPROVE NUTRITIONAL STATUS IN RETROPERITONEAL SARCOMA PATIENTS, WITH POSITIVE EFFECT ON SURGICAL MORBIDITY.

    Author: Marco Baia, MD (he/him/his) – Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Claudia Zanframundo, MD (she/her/hers) – Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Alessandro Maria Misotti, RD, MSc (he/him/his) – Clinical Nutrition Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Serena Della Valle, MD – Clinical Nutrition Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Nicolò Nuccio Rampello, Case Manager – Sarcoma Unit, Departments of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Sandro Pasquali, MD, PhD (he/him/his) – Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Stefano Radaelli, MD – Sarcoma Service, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

    Co-Author: Dario Callegaro, MD – Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Chiara Colombo, MD – Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Silva Ljevar, MSc (she/her/hers) – Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Co-Author: Rosalba Miceli, MD, PhD (she/her/hers) – Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Presenter: Marco Fiore, MD, FEBS, FACS – Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy